日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Phase 2 multicenter maintenance study of golidocitinib, A JAK1 selective inhibitor, in patients with peripheral T cell lymphomas after first-line systemic therapy (JACKPOT26)

针对接受一线全身治疗后外周T细胞淋巴瘤患者的 JAK1 选择性抑制剂 golidocitinib 的 II 期多中心维持治疗研究 (JACKPOT26)

Wei, Juying; Cai, Qingqing; Zhang, Liling; Zou, Liqun; Li, Zengjun; Zhou, Keshu; Wu, Huijing; Qiu, Lihua; Su, Liping; Ding, Kaiyang; Zhou, Hui; Yu, Li; Li, Fei; Li, Wenyu; Lin, Li'e; Xiao, Qing; Wang, Erhua; Jing, Hongmei; Zheng, Meifang; Zhang, Hongyu; Gao, Yuhuan; Gao, Da; Chen, Lijia; Jin, Jie

A comprehensive analysis of pirtobrutinib in Chinese patients with chronic lymphocytic leukaemia/small lymphocytic lymphoma (CLL/SLL): Results from the phase 3 study BRUIN CLL-321

对中国慢性淋巴细胞白血病/小淋巴细胞淋巴瘤 (CLL/SLL) 患者使用吡托布替尼的综合分析:来自 3 期研究 BRUIN CLL-321 的结果

Yi, Shuhua; Cao, Jiang; Feng, Ru; Zhou, Keshu; Qiu, Lihua; Li, Fei; Yang, Hai Yan; Zhou, Hui; Hui, Wuhan; Cui, Jie; Huang, He; Zhu, Jiankun; Ye, Xiuhui; Sharman, Jeff; Qiu, Lugui

Gray matter atrophy mediated the association between glymphatic function and cognition in Alzheimer's disease: a multicenter DTI-ALPS study

灰质萎缩介导了阿尔茨海默病中淋巴系统功能与认知之间的关联:一项多中心DTI-ALPS研究

Li, Zijun; Chen, Haotian; Qiu, Lihua; Li, Hongwei; Li, Shujiao; Wang, Yishuang; Li, Xiaojia; Ye, Fang; Wang, Yuting

The causal association between the new gut microbiota and Alzheimer's disease: A Mendelian randomization study

新肠道菌群与阿尔茨海默病之间的因果关系:一项孟德尔随机化研究

Lin, Fengwen; Yang, Xueqiang; Xie, Xuelong; Qiu, Lihua; Zheng, Congyang; Zheng, Xuxiang; Li, Zhongxun; Nie, Bin

Occult cervical large cell neuroendocrine carcinoma masquerading as adenocarcinoma in situ during pregnancy: a case report, literature review, and SEER analysis

妊娠期隐匿性宫颈大细胞神经内分泌癌误诊为原位腺癌:病例报告、文献回顾及SEER分析

Hu, Yifan; Li, Danhui; Qiu, Lihua; Di, Wen

Fn14 Controls the SIRT2-Mediated Deacetylation of Slug to Inhibit the Metastasis of Epithelial Ovarian Cancer.

Fn14 控制 SIRT2 介导的 Slug 去乙酰化,从而抑制上皮性卵巢癌的转移

Wu Anyue, Li Shengze, Feng Chunyang, He Ruiju, Wu Ruolan, Hu Zhijun, Huang Jinhua, Wang Wenjing, Huang Lei, Qiu Lihua

Efficacy and safety of tazemetostat, an EZH2 inhibitor, in Chinese patients with relapsed/refractory follicular lymphoma: a multicentre, single-arm, phase 2 study

tazemetostat(一种 EZH2 抑制剂)治疗中国复发/难治性滤泡性淋巴瘤患者的疗效和安全性:一项多中心、单臂 II 期研究

Cao, Junning; Chen, Guangliang; Qiu, Lihua; Zhang, Liling; Jiang, Ming; Cheng, Ying; Zhang, Qiaohua; Liu, Lihong; Li, Ping; Shuang, Yuerong; Wang, Huaqing; Xue, Hongwei; Wu, Huijing; Zheng, Meifang; Zhou, Keshu; Li, Zhiming; Jing, Hongmei; Yang, Wei; Zhu, Zunmin; Li, Wenyu; Wangwu, Jiaxuan; Huang, Heyu; Jia, Qiantao; Chen, Dongmei; Fan, Songhua; Shi, M Ming; Su, Weiguo

Adverse events in the nervous system associated with blinatumomab: a real-world study

blinatumomab相关神经系统不良事件:一项真实世界研究

Gao, Wen; Yu, Jingwei; Sun, Yifei; Song, Zheng; Liu, Xia; Han, Xue; Li, Lanfan; Qiu, Lihua; Zhou, Shiyong; Qian, Zhengzi; Wang, Xianhuo; Zhang, Huilai

Clinical outcomes of newly diagnosed PCNSL treated with rituximab-methotrexate-cytarabine with or without ibrutinib: a retrospective study

利妥昔单抗-甲氨蝶呤-阿糖胞苷联合或不联合伊布替尼治疗新诊断的原发性中枢神经系统淋巴瘤的临床结果:一项回顾性研究

Wang, Wenhua; Wang, Bingyi; Sun, Yifei; Qiu, Lihua; Qian, Zhengzi; Zhou, Shiyong; Song, Zheng; Li, Wei; Zhang, Xudong; Li, Lanfang; Wang, Xianhuo; Zhang, Huilai

Correction: Clinical outcomes of newly diagnosed PCNSL treated with rituximab-methotrexate-cytarabine with or without ibrutinib: a retrospective study

更正:利妥昔单抗-甲氨蝶呤-阿糖胞苷联合或不联合伊布替尼治疗新诊断的原发性中枢神经系统淋巴瘤的临床结果:一项回顾性研究

Wang, Wenhua; Wang, Bingyi; Sun, Yifei; Qiu, Lihua; Qian, Zhengzi; Zhou, Shiyong; Song, Zheng; Li, Wei; Zhang, Xudong; Li, Lanfang; Wang, Xianhuo; Zhang, Huilai